Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?

Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?

<p><strong>Background</strong> Immune checkpoint inhibitors (ICI) improve survival but cause immune-related adverse events (irAE). We sought to determine if CTCAE classification, IBD biomarkers/endoscopic/histological scores correlate with irAE colitis outcomes.</p> <p>...

书目详细资料
Main Authors:	Cheung, VTF, Gupta, T, Olsson-Brown, A, Subramanian, S, Sasson, SC, Heseltine, J, Fryer, E, Collantes, E, Sacco, JJ, Pirmohamed, M, Simmons, A, Klenerman, P, Tuthill, M, Protheroe, AS, Chitnis, M, Fairfax, BP, Payne, MJ, Middleton, MR, Brain, O
格式:	Journal article
语言:	English
出版:	Springer Nature 2020

相似书籍

Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis
由: Sasson, SC, et al.
出版: (2019)

Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma
由: Sasson, SC, et al.
出版: (2021)

Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis
由: Sasson, SC, et al.
出版: (2020)

Two distinct clinical patterns of checkpoint inhibitor-induced thyroid dysfunction
由: Anna Olsson-Brown, et al.
出版: (2020-04-01)

IBD in the elderly - beware of pitfalls!
由: Mohmmed T Sharip, et al.
出版: (2023-01-01)

Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma
由: S. C. Sasson, et al.
出版: (2021-09-01)

Microbiota and IBD
由: M. Aberg, et al.
出版: (2020-06-01)

Immunotherapy-related hepatitis: real-world experience from a tertiary centre
由: Cheung, V, et al.
出版: (2019)

Fertility and reproduction in a tertiary IBD centre: the Oxford experience
由: Lee, L, et al.
出版: (2018)

Anorexia, vomiting and weight loss in a 22-year-old woman
由: Cheung, V, et al.
出版: (2018)

IBD and Diet
由: Ilene Gilbert, et al.
出版: (1994-01-01)

IBD or strongyloidiasis?
由: Marta Maia Boscá-Watts, et al.

Microbiota and IBD
由: B. Wu, et al.
出版: (2020-01-01)

Validation of the Portuguese Version of IBD-Control Questionnaire and Comparison with IBD-Disk
由: Tânia Carvalho, et al.
出版: (2024-10-01)

Surveillance colonoscopy in PSC-IBD: Some answers but more questions remain
由: Nilanga Nishad, et al.
出版: (2025-01-01)

Biosimilars in IBD: hope or expectation?
由: Gecse, K, et al.
出版: (2013)

Is IBD different in the elderly?
由: Travis, S
出版: (2008)

IBD: Progress in Pathogenesis
由: Claudio Fiocchi, et al.
出版: (1993-01-01)

IBD considerations in spondyloarthritis
由: Caroline Di Jiang, et al.
出版: (2020-07-01)

IBD and the gut microbiota
由: C. Mah, et al.
出版: (2021-09-01)

Immune checkpoint blockade sensitivity and progression-free survival associates with baseline CD8+ T cell clone size and cytotoxicity
由: Watson, RA, et al.
出版: (2021)

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
由: Jessica Mwinyi, et al.
出版: (2012-01-01)

Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study.
由: Lorenz Bon, et al.
出版: (2019-01-01)

RIPK2 NODs to XIAP and IBD
由: Topal, Y, et al.
出版: (2020)

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma
由: Taylor, CA, et al.
出版: (2022)

IBD2020 global forum: Results of an international patient survey on quality of care.
由: Irving, P, et al.
出版: (2018)

Insomnia is common in inflammatory bowel disease (IBD) and is associated with mental health conditions as well as IBD activity
由: Alex Barnes, et al.
出版: (2024-01-01)

Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
由: Alex Barnes, et al.
出版: (2022-10-01)

Year in microbiota: IBD clinical studies
由: T. Jayawardana, et al.
出版: (2023-10-01)

Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic
由: McGregor, CG, et al.
出版: (2021)

Self-Management assistance for recommended treatment (SMART) IBD app randomized control trial in adolescents with IBD: Design and methodology
由: Caroline M. Roberts, et al.
出版: (2024-01-01)

How to Evaluate Fibrosis in IBD?
由: Helena Tavares de Sousa, et al.
出版: (2023-06-01)

Endoscopy in IBD: When and How?
由: Marco Daperno
出版: (2023-11-01)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
由: Jihye Park, et al.
出版: (2021-09-01)

The Gut-Brain Axis in IBD: An Investigator’s Perspective
由: Stephen M Collins, et al.
出版: (1995-01-01)

Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis
由: Gonzalo Saiz-Gonzalo, et al.
出版: (2021-07-01)

Histopathology and transmission electron microscopy of the bursa of fabricius following ibd vaccination and ibd virus challenge in chickens
由: Amelia Luengo, et al.
出版: (2010-06-01)

Social barriers influence inflammatory bowel disease (IBD) outcomes and disproportionally affect Hispanics and non-Hispanic Blacks with IBD
由: Oriana M. Damas, et al.
出版: (2022-03-01)

IBD2020 global forum: results of an international patient survey on quality of care
由: Peter Irving, et al.
出版: (2018-10-01)

What Will Research Tell Us About the Future in IBD?
由: Stephen M Collins, et al.
出版: (1993-01-01)